SynthesisBMC medicine2026

Extrapolating from trials to clinic: a predictive model defining the boundaries of benefit for multiple sclerosis therapies in real-world populations based on systematic review.

Bibiana Bielekova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.